Natural killer-dendritic cell interaction in lymphocyte responses in hypersensitivity reactions to betalactams

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 12, 2010, Pages 1600-1608

  Chaves, P ^a   Torres, M J ^a   Aranda, A ^a   Lopez, S ^a   Canto, G ^b   Blanca, M ^a   Mayorga, C ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

Author keywords

Allergic reactions; Dendritic cells; Drugs; NK lymphocytes; T lymphocytes

Indexed keywords

AMOXICILLIN; CD69 ANTIGEN; CLAVULANIC ACID; GAMMA INTERFERON; GRANZYME B; LIPOCORTIN 5; PERFORIN;

ADULT; AGED; ARTICLE; CELL INTERACTION; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; DRUG HYPERSENSITIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERSENSITIVITY REACTION; IMMUNOPATHOLOGY; INTERFERON PRODUCTION; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MACULOPAPULAR RASH; MALE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; URTICARIA;

ADOLESCENT; ADULT; AGED; AMOXICILLIN; CELL COMMUNICATION; CELL SEPARATION; DENDRITIC CELLS; DRUG HYPERSENSITIVITY; FEMALE; FLOW CYTOMETRY; GRANZYMES; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PERFORIN; T-LYMPHOCYTES;

EID: 78349264226     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02459.x     Document Type: Article

References (35)

1. Gruchalla RS, Pirmohamed M,. Clinical practice. Antibiotic allergy. N Engl J Med 2006; 354: 601 -609.
2. Lopez S, Blanca-Lopez N, Cornejo-Garcia JA, Canto G, Torres MJ, Mayorga C, etal. Nonimmediate reactions to betalactams. Curr Opin Allergy Clin Immunol 2007; 7: 310 -316.
3. Posadas SJ, Torres MJ, Mayorga C, Juarez C, Blanca M,. Gene expression levels of cytokine profile and cytotoxic markers in non-immediate reactions to drugs. Blood Cells Mol Dis 2002; 29: 179 -189.
4. Fernandez TD, Mayorga C, Torres MJ, Cornejo-Garcia JA, Lopez S, Chaves P, etal. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs. Allergy 2008; 63: 712 -719.
5. Cornejo-Garcia JA, Fernandez TD, Torres MJ, Carballo M, Hernan I, Antunez C, etal. Differential cytokine and transcription factor expression in patients with allergic reactions to drugs. Allergy 2007; 62: 1429 -1438.
6. Fehniger TA, Cooper MA, Nuovo GJ, Cella M, Facchetti F, Colonna M, etal. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003; 101: 3052 -3057.
7. Morel E, Bellon T,. Amoxicillin conjugates to HLA class I molecules and interferes with signalling through the ILT2/LIR-1/CD85j inhibitory receptor. Allergy 2007; 62: 190 -196.
8. Korsgren M,. NK cells and asthma. Curr Pharm Des 2002; 8: 1871 -1876.
9. French AR, Yokoyama WM,. Natural killer cells and autoimmunity. Arthritis Res Ther 2004; 6: 8 -14.
10. Pichler WJ,. Delayed drug hypersensitivity reactions. Ann Intern Med 2003; 139: 683 -693.
11. Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P, etal. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 2004; 114: 1209 -1215.
12. Chung WH, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, etal. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008; 14: 1343 -1350.
13. Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E,. Natural-killer cells and dendritic cells: "lunion fait la force". Blood 2005; 106: 2252 -2258.
14. Trinchieri G,. Biology of natural killer cells. Adv Immunol 1989; 47: 187 -376.
15. Orange JS, Ballas ZK,. Natural killer cells in human health and disease. Clin Immunol 2006; 118: 1 -10.
16. Cooper MA, Fehniger TA, Caligiuri MA,. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22: 633 -640.
17. Ferlazzo G, Thomas D, Lin SL, Goodman K, Morandi B, Muller WA, etal. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 2004; 172: 1455 -1462.
18. Marcenaro E, Ferranti B, Moretta A,. NK-DC interaction: on the usefulness of auto-aggression. Autoimmun Rev 2005; 4: 520 -525.
19. Ferlazzo G, Pack M, Thomas D, Paludan C, Schmid D, Strowig T, etal. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci USA 2004; 101: 16606 -16611.
20. Vitale M, Della Chiesa M, Carlomagno S, Romagnani C, Thiel A, Moretta L, etal. The small subset of CD56brightCD16-natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur J Immunol 2004; 34: 1715 -1722.
21. Zhang C, Zhang J, Tian Z,. The regulatory effect of natural killer cells: do "NK-reg cells" exist? Cell Mol Immunol 2006; 3: 241 -254.
22. Romano A, Blanca M, Torres MJ, Bircher A, Aberer W, Brockow K, etal. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy 2004; 59: 1153 -1160.
23. Sallusto F, Lanzavecchia A,. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109 -1118.
24. Rodriguez-Pena R, Lopez S, Mayorga C, Antunez C, Fernandez TD, Torres MJ, etal. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams. J Allergy Clin Immunol 2006; 118: 949 -956.
25. Antunez C, Torres MJ, Mayorga C, Cornejo-Garcia JA, Santamaria-Babi LF, Blanca M,. Different cytokine production and activation marker profiles in circulating cutaneous-lymphocyte-associated antigen T cells from patients with acute or chronic atopic dermatitis. Clin Exp Allergy 2004; 34: 559 -566.
26. Torres MJ, Mayorga C, Fernandez TD, Cornejo-Garcia JA, Antunez C, Valenzuela M, etal. T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence. Int J Immunopathol Pharmacol 2006; 19: 119 -130.
27. Banchereau J, Steinman RM,. Dendritic cells and the control of immunity. Nature 1998; 392: 245 -252.
28. Zawodniak A, Lochmatter P, Yerly D, Kawabata T, Lerch M, Yawalkar N, etal. In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug-induced skin diseases. Allergy 2010; 65: 376 -384.
29. Ren G, Su J, Zhao X, Zhang L, Zhang J, Roberts AI, etal. Apoptotic cells induce immunosuppression through dendritic cells: critical roles of IFN-gamma and nitric oxide. J Immunol 2008; 181: 3277 -3284.
30. Ida H, Nakashima T, Kedersha NL, Yamasaki S, Huang M, Izumi Y, etal. Granzyme B leakage-induced cell death: a new type of activation-induced natural killer cell death. Eur J Immunol 2003; 33: 3284 -3292.
31. Moretta A,. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002; 2: 957 -964.
32. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C,. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002; 195: 343 -351.
33. Moretta L, Bottino C, Pende D, Vitale M, Mingari MC, Moretta A,. Human natural killer cells: molecular mechanisms controlling NK cell activation and tumor cell lysis. Immunol Lett 2005; 100: 7 -13.
34. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G,. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002; 195: 327 -333.
35. Carbone T, Nasorri F, Pennino D, Eyerich K, Foerster S, Cifaldi L, etal. CD56highCD16-CD62L-NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses. J Immunol 2010; 184: 1102 -1110.